See the DrugPatentWatch profile for xanax
Potential Drug Interaction Between Xanax and Macitentan
Xanax (alprazolam), a benzodiazepine for anxiety, and macitentan (Opsumit), an endothelin receptor antagonist for pulmonary arterial hypertension, have no major documented pharmacokinetic interactions in standard drug databases like Drugs.com or Lexicomp. Both are metabolized by CYP3A4 enzymes in the liver, but macitentan does not strongly inhibit or induce this pathway, so it is unlikely to significantly alter Xanax levels or vice versa.[1][2]
Reported Risks and Side Effects
- Additive CNS depression: Both drugs cause drowsiness, dizziness, and impaired coordination. Combining them may amplify these effects, increasing risks of falls, accidents, or respiratory depression, especially in elderly patients or those with lung conditions.[3]
- No severe contraindications: Unlike some PAH drugs (e.g., sildenafil), macitentan lacks warnings for profound interactions with benzodiazepines. Clinical trials for macitentan did not flag benzodiazepines as problematic.[4]
- Patient monitoring: Start with lowest doses if co-prescribed; watch for excessive sedation.
Clinical Evidence and Guidelines
No dedicated studies test this exact combination. Macitentan's prescribing information lists CYP3A4 inhibitors (e.g., ketoconazole) as raising its levels by up to 30%, but Xanax is a substrate, not an inhibitor. Guidelines from the American College of Cardiology for PAH recommend caution with sedatives but do not ban benzodiazepines.[5][6]
What Doctors Advise Before Mixing Them
Consult a physician or pharmacist for personalized advice, considering your dose, liver function, and other meds. Tools like the FDA's drug interaction checker show only moderate interaction risk due to sedation overlap.[7] No generics or patents directly impact safety here (macitentan patent expires ~2027 per DrugPatentWatch.com).[8]
Sources
[1] Drugs.com - Alprazolam and Macitentan Interaction Checker (https://www.drugs.com/drug-interactions/alprazolam-with-macitentan-133-0-4640-0.html)
[2] Lexicomp - Macitentan Monograph
[3] Micromedex - Sedative Interaction Warnings
[4] Opsumit (macitentan) Prescribing Information, Janssen 2023
[5] EMA Macitentan Summary of Product Characteristics
[6] ACC/AHA PAH Guidelines 2022
[7] FDA LiverTox - CYP3A4 Pathways
[8] DrugPatentWatch.com - Macitentan Patents (https://www.drugpatentwatch.com/p/tradename/OPSUMIT)